Merve Horoz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Merve Horoz has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Mehmet Coskun
Department of Radiology, University of Health Sciences, İzmir Dr. Behçet Uz Children’s Hospital, İzmir, Türkiye image/svg+xml
6 shared publications - Mustafa Fazil Gelal
Department of Radiology, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey
4 shared publications - Engin Uluç
İZMİR KATİP ÇELEBİ ÜNİVERSİTES
3 shared publications - Kazim Ayberk Sinci
Department of Radiology, Kanuni Sultan Suleyman Education and Research Hospital, İstanbul, Türkiye
3 shared publications - Yusuf Kenan Çetinoğlu
Department of Radiology, Behçet Uz Children’s Hospital, Izmir, Turkey
3 shared publications - Ali Salbas
Izmir Katip Celebi University, Ataturk Training and Research Hospital, Department of Radiology, Izmir, Turkey (A.S.).
2 shared publications
Latest Publications
- Open Access
- 15 October 2025
- Published by Springer Nature in BMC Medical Imaging
- Vol. 25 (1) , 1-12
Multiparametric MRI characteristics for differentiating primary cancer origin in brain metastases
Background: Accurate identification of primary cancer origin in brain metastases (BMs) is crucial for diagnosis and treatment planning. Identification is challenging, particularly in unknown primary cases. Multiparametric Magnetic Resonance Imaging (MRI) offers non-invasive imaging characteristics as diagnostic clues. This study aimed to investigate the relationship between multiparametric MRI features of BMs and their primary tumor origin. Methods: This retrospective study included 125 patients with intra-axial brain metastases, classified as breast cancer, small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC), malignant melanoma, and other cancers. Multiparametric MRI, including T2-FLAIR, contrast-enhanced 3D T1-weighted imaging, apparent diffusion coefficient (ADC) maps, susceptibility-weighted imaging (SWI), and cerebral blood volume (CBV) maps, was performed. Lesion volume, necrotic volume, necrosis ratio, peritumoral edema volume, and edema ratio were measured. 3D Slicer® software was used for semi-automated volumetric measurements. Quantitative ADC and rCBV values, intratumoral susceptibility signal (ITSS) scores, and metastasis number and location were analyzed to differentiate primary tumor origins. Results: 291 metastatic lesions from 125 patients were analyzed. NSCLC metastases showed significantly higher necrosis ratios than breast (p < 0.001) and SCLC (p = 0.025) metastases. Malignant melanoma metastases exhibited significantly higher edema ratios than breast (p = 0.001) and SCLC (p = 0.004) metastases. NSCLC metastases also showed a significantly higher edema ratio than breast (p = 0.011) metastases. Mean ADC values were significantly higher in NSCLC metastases compared to all other groups, with an optimal cut-off of ≥ 0.905 mm²/s (AUC: 0.775). Malignant melanoma and SCLC metastases had significantly higher rCBV values than breast cancer metastases. Malignant melanoma metastases consistently showed the highest ITSS scores among all groups, with an optimal cut-off of ≥ 1 (AUC: 0.769). Furthermore, multiple metastases ≤ 0.5 cm³ were significantly associated with breast cancer (p = 0.041). Infratentorial metastases were more prevalent in breast cancer (OR = 2.490, p = 0.001). Conclusion: Brain metastases exhibit distinct multiparametric MRI characteristics by primary cancer origin. Breast cancer metastases tend to be smaller, multiple, and infratentorial. NSCLC metastases show greater necrosis and higher ADC values, while melanoma metastases demonstrate higher intratumoral susceptibility. These features offer valuable diagnostic clues for differentiating primary cancer types in patients with brain metastases. Clinical trial number: Not applicable.
- 15 October 2025
- Published by Springer Nature in BMC Medical Imaging
- Vol. 25 (1) , 1-12
Open AccessMultiparametric MRI characteristics for differentiating primary cancer origin in brain metastases
Background: Accurate identification of primary cancer origin in brain metastases (BMs) is crucial for diagnosis and treatment planning. Identification is challenging, particularly in unknown primary cases. Multiparametric Magnetic Resonance Imaging (MRI) offers non-invasive imaging characteristics as diagnostic clues. This study aimed to investigate the relationship between multiparametric MRI features of BMs and their primary tumor origin. Methods: This retrospective study included 125 patients with intra-axial brain metastases, classified as breast cancer, small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC), malignant melanoma, and other cancers. Multiparametric MRI, including T2-FLAIR, contrast-enhanced 3D T1-weighted imaging, apparent diffusion coefficient (ADC) maps, susceptibility-weighted imaging (SWI), and cerebral blood volume (CBV) maps, was performed. Lesion volume, necrotic volume, necrosis ratio, peritumoral edema volume, and edema ratio were measured. 3D Slicer® software was used for semi-automated volumetric measurements. Quantitative ADC and rCBV values, intratumoral susceptibility signal (ITSS) scores, and metastasis number and location were analyzed to differentiate primary tumor origins. Results: 291 metastatic lesions from 125 patients were analyzed. NSCLC metastases showed significantly higher necrosis ratios than breast (p < 0.001) and SCLC (p = 0.025) metastases. Malignant melanoma metastases exhibited significantly higher edema ratios than breast (p = 0.001) and SCLC (p = 0.004) metastases. NSCLC metastases also showed a significantly higher edema ratio than breast (p = 0.011) metastases. Mean ADC values were significantly higher in NSCLC metastases compared to all other groups, with an optimal cut-off of ≥ 0.905 mm²/s (AUC: 0.775). Malignant melanoma and SCLC metastases had significantly higher rCBV values than breast cancer metastases. Malignant melanoma metastases consistently showed the highest ITSS scores among all groups, with an optimal cut-off of ≥ 1 (AUC: 0.769). Furthermore, multiple metastases ≤ 0.5 cm³ were significantly associated with breast cancer (p = 0.041). Infratentorial metastases were more prevalent in breast cancer (OR = 2.490, p = 0.001). Conclusion: Brain metastases exhibit distinct multiparametric MRI characteristics by primary cancer origin. Breast cancer metastases tend to be smaller, multiple, and infratentorial. NSCLC metastases show greater necrosis and higher ADC values, while melanoma metastases demonstrate higher intratumoral susceptibility. These features offer valuable diagnostic clues for differentiating primary cancer types in patients with brain metastases. Clinical trial number: Not applicable.
- Open Access
- 14 May 2025
- Published by Springer Nature in BMC Medical Imaging
- Vol. 25 (1) , 1-12
Temporal evolution of MRI findings and survival outcomes in patients with brain metastases after stereotactic radiosurgery
This study aims to investigate the temporal evolution of magnetic resonance imaging (MRI) findings in brain metastases following stereotactic radiosurgery (SRS) and their correlation with treatment response and survival outcomes. By analyzing volumetric changes in tumor size, perilesional edema, and necrotic components, we seek to identify imaging biomarkers that predict prognosis and treatment efficacy. A retrospective analysis was conducted on 97 patients (200 metastatic lesions) who underwent SRS for brain metastases between 2010 and 2022. Multiparametric MRI (MPMRI) scans were analyzed at four distinct follow-up periods: 1 to 3 months, 3 to 8 months, 8 to 16 months, and 16 to 24 months post-SRS. Volumetric measurements of tumor size, perilesional edema, and necrosis were obtained using semi-automated segmentation. Apparent diffusion coefficient (ADC) values and relative cerebral blood volume (rCBV) ratios were also assessed. Statistical analyses, including Kaplan-Meier survival curves and ROC analysis, were performed to determine prognostic imaging biomarkers. The most significant reduction in tumor and perilesional edema volume occurred within the first 1 to 3 months post-SRS and continued until the 8th month. A transient increase in lesion size (pseudoprogression) was observed in 31.5% of cases, predominantly between 3 and 8 months post-SRS. Pretreatment tumor volume was found to be significantly associated with treatment response. ROC analysis identified 1.22 cm³ as the optimal cutoff value for differentiating between Group A (good response) and Group B (poor response) lesions (AUC = 0.754, sensitivity = 87.0%, specificity = 57.1%). Survival analysis revealed that higher pretreatment tumor volume, larger necrotic volume, and extensive perilesional edema were associated with shorter survival times (p < 0.05). No significant association was found between survival and ADC or rCBV. Following SRS, early reductions in tumor and edema volume were observed, while 31.5% of cases showed transient enlargement. Smaller tumors responded better to SRS, whereas larger volume, extensive edema, and necrosis were linked to shorter survival. Given the high rate of pseudoprogression, not every post-treatment size increase indicates true progression. A wait-and-see approach may help avoid unnecessary interventions in selected cases. Not applicable.
- 14 May 2025
- Published by Springer Nature in BMC Medical Imaging
- Vol. 25 (1) , 1-12
Open AccessTemporal evolution of MRI findings and survival outcomes in patients with brain metastases after stereotactic radiosurgery
This study aims to investigate the temporal evolution of magnetic resonance imaging (MRI) findings in brain metastases following stereotactic radiosurgery (SRS) and their correlation with treatment response and survival outcomes. By analyzing volumetric changes in tumor size, perilesional edema, and necrotic components, we seek to identify imaging biomarkers that predict prognosis and treatment efficacy. A retrospective analysis was conducted on 97 patients (200 metastatic lesions) who underwent SRS for brain metastases between 2010 and 2022. Multiparametric MRI (MPMRI) scans were analyzed at four distinct follow-up periods: 1 to 3 months, 3 to 8 months, 8 to 16 months, and 16 to 24 months post-SRS. Volumetric measurements of tumor size, perilesional edema, and necrosis were obtained using semi-automated segmentation. Apparent diffusion coefficient (ADC) values and relative cerebral blood volume (rCBV) ratios were also assessed. Statistical analyses, including Kaplan-Meier survival curves and ROC analysis, were performed to determine prognostic imaging biomarkers. The most significant reduction in tumor and perilesional edema volume occurred within the first 1 to 3 months post-SRS and continued until the 8th month. A transient increase in lesion size (pseudoprogression) was observed in 31.5% of cases, predominantly between 3 and 8 months post-SRS. Pretreatment tumor volume was found to be significantly associated with treatment response. ROC analysis identified 1.22 cm³ as the optimal cutoff value for differentiating between Group A (good response) and Group B (poor response) lesions (AUC = 0.754, sensitivity = 87.0%, specificity = 57.1%). Survival analysis revealed that higher pretreatment tumor volume, larger necrotic volume, and extensive perilesional edema were associated with shorter survival times (p < 0.05). No significant association was found between survival and ADC or rCBV. Following SRS, early reductions in tumor and edema volume were observed, while 31.5% of cases showed transient enlargement. Smaller tumors responded better to SRS, whereas larger volume, extensive edema, and necrosis were linked to shorter survival. Given the high rate of pseudoprogression, not every post-treatment size increase indicates true progression. A wait-and-see approach may help avoid unnecessary interventions in selected cases. Not applicable.
- 13 May 2025
- Published by Taylor & Francis in Acta Chirurgica Belgica
- p. 1-7
Plain versus drug-eluting balloon angioplasty in the treatment of non-thrombotic hemodialysis arteriovenous fistula stenosis: results from a single center comparative retrospective analysis
To compare the mid-term primary and assisted-primary patency results of plain balloon angioplasty (PBA) versus drug-eluting balloon angioplasty (DEB) with non-thrombotic arteriovenous fistula (AVF) stenosis in hemodialysis (HD) patients. A total of 128 consecutive HD patients, who underwent endovascular treatment with DEB or PBA between October 2015 and December 2021, were investigated in this retrospective study. Color Doppler examination was performed for follow-up after 1, 3, 6, 12, 18, 24, and 36 months. Survival curves for primary and assisted primary vein patencies of the PTA and DEB group were generated with Kaplan-Meier survival analysis and were compared with the log-rank test. 78 patients (60.9%) underwent PBA (45 men, 33 women; mean age: 64.2 ± 13.9, range: 29-82 years) and 50 (39%) patients underwent DEB (36 men, 14 women; mean age: 65.6 ± 12.8, range: 28-87 years). The estimated primary patency rates at 6, 12,18, 24, and 36 months for the DEB group (95.5%, 92.8%, 88.6%, 77.1% and 54.0%, respectively) were significantly higher than those in the PBA group (84.5%, 76.9%, 73.9%, 66.4% and 59.0%, respectively) (p= 0.048). Assisted primary patency rates at 6, 12, 18, 24, and 36 months were higher in the DEB group (97.9%, 95.4%, 90.2%, 87.3% and 75.5%, respectively) than PBA group (94.7%, 86.9%, 85.0%, 78.0%, and 66.9%, respectively) but they were not statistically significant (p = 0.187). Our study confirms DEB is a safe and effective treatment of dysfunctional AVF. We demonstrate higher primary patency rates in DEB than PBA at 6, 12, 18, 24 and 36 months. However, no statistically significant were detected between the two groups in mid-term follow-up.
- 13 May 2025
- Published by Taylor & Francis in Acta Chirurgica Belgica
- p. 1-7
Plain versus drug-eluting balloon angioplasty in the treatment of non-thrombotic hemodialysis arteriovenous fistula stenosis: results from a single center comparative retrospective analysis
To compare the mid-term primary and assisted-primary patency results of plain balloon angioplasty (PBA) versus drug-eluting balloon angioplasty (DEB) with non-thrombotic arteriovenous fistula (AVF) stenosis in hemodialysis (HD) patients. A total of 128 consecutive HD patients, who underwent endovascular treatment with DEB or PBA between October 2015 and December 2021, were investigated in this retrospective study. Color Doppler examination was performed for follow-up after 1, 3, 6, 12, 18, 24, and 36 months. Survival curves for primary and assisted primary vein patencies of the PTA and DEB group were generated with Kaplan-Meier survival analysis and were compared with the log-rank test. 78 patients (60.9%) underwent PBA (45 men, 33 women; mean age: 64.2 ± 13.9, range: 29-82 years) and 50 (39%) patients underwent DEB (36 men, 14 women; mean age: 65.6 ± 12.8, range: 28-87 years). The estimated primary patency rates at 6, 12,18, 24, and 36 months for the DEB group (95.5%, 92.8%, 88.6%, 77.1% and 54.0%, respectively) were significantly higher than those in the PBA group (84.5%, 76.9%, 73.9%, 66.4% and 59.0%, respectively) (p= 0.048). Assisted primary patency rates at 6, 12, 18, 24, and 36 months were higher in the DEB group (97.9%, 95.4%, 90.2%, 87.3% and 75.5%, respectively) than PBA group (94.7%, 86.9%, 85.0%, 78.0%, and 66.9%, respectively) but they were not statistically significant (p = 0.187). Our study confirms DEB is a safe and effective treatment of dysfunctional AVF. We demonstrate higher primary patency rates in DEB than PBA at 6, 12, 18, 24 and 36 months. However, no statistically significant were detected between the two groups in mid-term follow-up.
- Open Access
- 17 March 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (6) , 1411-1421
Qualitative MRI features in the differentiation between primary and secondary CNS lymphoma
Purpose: Differentiating between primary CNS lymphomas (PCNSL) and secondary CNS lymphomas (SCNSL) remains a challenge in imaging. The aim of this study was to differentiate histopathologically-proven PCNSL and SCNSL by using 25 qualitative VASARI and five other MRI features. Methods: MRIs of 31 cases (19 PCNSL and 12 SCNSL) obtained between January 2010 and February 2022 were retrospectively reviewed. Two blinded readers independently evaluated images without knowledge of clinical data or whether CNS lymphoma was primary or secondary. The findings of each reader were recorded to assess interreader agreement. The results of two readers were evaluated by a senior neuroradiologist to reach a consensus. A statistical analysis was performed on the collected data. Results: Most VASARI features showed no statistically significant differences between the two groups, except for two features. Tumor location exhibited a statistically different distribution between PCNSL and SCNSL groups (p = 0.036). Proportion of edema was greater in the PCNSL group compared to the SCNSL group (p = 0.049). Among other MRI features, infratentorial involvement was more frequent in the SCNSL group (p = 0.014), while notch sign was more commonly detected in the PCNSL group (p = 0.027). Inter-reader agreement for VASARI features ranged from moderate to almost perfect, and for other MRI features, it ranged from fair to almost perfect. Conclusion: Despite the challenges in distinguishing imaging features of PCNSL and SCNSL; frontal lobe location, a higher proportion of edema and the presence of a notch sign may indicate PCNSL, while infratentorial involvement may suggest SCNSL.
- 17 March 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (6) , 1411-1421
Open AccessQualitative MRI features in the differentiation between primary and secondary CNS lymphoma
Purpose: Differentiating between primary CNS lymphomas (PCNSL) and secondary CNS lymphomas (SCNSL) remains a challenge in imaging. The aim of this study was to differentiate histopathologically-proven PCNSL and SCNSL by using 25 qualitative VASARI and five other MRI features. Methods: MRIs of 31 cases (19 PCNSL and 12 SCNSL) obtained between January 2010 and February 2022 were retrospectively reviewed. Two blinded readers independently evaluated images without knowledge of clinical data or whether CNS lymphoma was primary or secondary. The findings of each reader were recorded to assess interreader agreement. The results of two readers were evaluated by a senior neuroradiologist to reach a consensus. A statistical analysis was performed on the collected data. Results: Most VASARI features showed no statistically significant differences between the two groups, except for two features. Tumor location exhibited a statistically different distribution between PCNSL and SCNSL groups (p = 0.036). Proportion of edema was greater in the PCNSL group compared to the SCNSL group (p = 0.049). Among other MRI features, infratentorial involvement was more frequent in the SCNSL group (p = 0.014), while notch sign was more commonly detected in the PCNSL group (p = 0.027). Inter-reader agreement for VASARI features ranged from moderate to almost perfect, and for other MRI features, it ranged from fair to almost perfect. Conclusion: Despite the challenges in distinguishing imaging features of PCNSL and SCNSL; frontal lobe location, a higher proportion of edema and the presence of a notch sign may indicate PCNSL, while infratentorial involvement may suggest SCNSL.
- Open Access
- 25 April 2023
- Published by Academician Publishing
Pediatrik Girişimsel Radyoloji
Pediatrik Girişimsel Radyolojiye Genel Bakış Çağrı ERDİM Girişimsel İşlemler Öncesi Hasta Değerlendirme Ezel YALTIRIK BİLGİN Girişimsel İşlem Öncesi Görüntüleme Teknikleri Sıla ÖZGÜRGÜN CANKAYA Pediatrik Girişimsel Radyolojide Anestezi Feryal KORKMAZ AKÇAY Baş ve Boyun Vasküler Anatomisi Mehmet TURMAK Baş-Boyun Vasküler Anomalileri Hüseyin Gökhan YAVAŞ Muhammed ALPASLAN Serebral Anjiyografi Teknik ve Uygulamalar Velihan ÇAYHAN Serebral Endovasküler Tedaviler Bige SAYIN Karotis Ve Vertebral Arter Girişimleri Emre ALP Baş Boyun Vasküler Tümörler Ali DABLAN Spinal Vasküler Anatomi ve Varyasyonlar Hamza ÖZER Pediatrik Spinal Endovasküler Girişimler Bige SAYIN Periferik Arteriyel Anatomi Betül AKDAL DÖLEK Pediatrik Anjıiografiye Genel Bakış Husam VEHBİ Pulmoner Vasküler Malformasyonlar Mehtap OKTAY Pulmoner Arter Girişimleri Mehmet CİNGÖZ Torasik Aorta Girişimsel İşlemleri Gökçe KAŞ İbrahim ECE Abdominal Aorta ve Pelvik Arter Girişimleri Erbil ARIK Gürkan DANIŞAN Renal Arter Girişimleri Muhammet Kürşat ŞİMŞEK İsmail DİLEK Üst Ekstremite Arteriyel Girişimleri Hülya ÇETİN TUNÇEZ Alt Ekstremite Arteriyel Girişimleri Ahmet BAYRAK İntravasküler Yabancı Cisim Çıkarılması İsmail DİLEK Muhammet Kürşat ŞİMŞEK Periferik Venöz Anatomi Seçil GÜNDOĞDU Pediyatrik Venografi’ye Genel Bakış Sevgi DEMİRÖZ TAŞOLAR Periferik Vasküler Malformasyonlar Mehmet TURMAK Muhammed TEKİNHATUN Pediatrik Santral Venöz Girişimler Çağrı DAMAR Boyun ve Üst Ekstremite Venöz Girişimleri Merve HOROZ DÖNMEZ Lenfanjiografi ve Duktus Torasikus Embolizasyonu Samet GENEZ Portal ve Hepatik Venöz Girişimler, Konjenital Portosistemik Şant Tanı ve Tedavisi Ahmet BAYRAK Görüntüleme Eşliğinde Perkütan Biyopsiler Emre ALP Plevral Efüzyon ve Ampiyem Tedavisi Betül AKDAL DÖLEK Perkütan Apse ve Sıvı Drenajları Mustafa REŞORLU Fırathan SARIALTIN Perkütan Kist Hidatik Tedavisi Gülsüm Kübra BAHADIR Perkütan Gastrointestinal Girişimler Gülsüm Kübra BAHADIR Perkütan Biliyer Girişimler Mahmut DEMİRCİ Perkütan Üriner Sistem Girişimleri Mustafa YILDIRIM Hakan ARTAŞ Ahmet Kürşad POYRAZ Çocuklarda Perkütan Basit Renal Kist Tedavisi ve Perkütan Nefrolitotomi Gülşah BAYRAM ILIKAN Görüntüleme Eşliğinde Meme Girişimleri Seçil GÜNDOĞDU Pediatrik Kas İskelet Sistemi Girişimsel İşlemleri Kadir Han ALVER Görüntüleme Eşliğinde Tümör Ablasyonu Temel Prensipleri Uğur KESİMAL Retinoblastomda İntraarteriyel Kemoterapi Bedia KESİMAL Uğur KESİMAL
- 25 April 2023
- Published by Academician Publishing
Open AccessPediatrik Girişimsel Radyoloji
Pediatrik Girişimsel Radyolojiye Genel Bakış Çağrı ERDİM Girişimsel İşlemler Öncesi Hasta Değerlendirme Ezel YALTIRIK BİLGİN Girişimsel İşlem Öncesi Görüntüleme Teknikleri Sıla ÖZGÜRGÜN CANKAYA Pediatrik Girişimsel Radyolojide Anestezi Feryal KORKMAZ AKÇAY Baş ve Boyun Vasküler Anatomisi Mehmet TURMAK Baş-Boyun Vasküler Anomalileri Hüseyin Gökhan YAVAŞ Muhammed ALPASLAN Serebral Anjiyografi Teknik ve Uygulamalar Velihan ÇAYHAN Serebral Endovasküler Tedaviler Bige SAYIN Karotis Ve Vertebral Arter Girişimleri Emre ALP Baş Boyun Vasküler Tümörler Ali DABLAN Spinal Vasküler Anatomi ve Varyasyonlar Hamza ÖZER Pediatrik Spinal Endovasküler Girişimler Bige SAYIN Periferik Arteriyel Anatomi Betül AKDAL DÖLEK Pediatrik Anjıiografiye Genel Bakış Husam VEHBİ Pulmoner Vasküler Malformasyonlar Mehtap OKTAY Pulmoner Arter Girişimleri Mehmet CİNGÖZ Torasik Aorta Girişimsel İşlemleri Gökçe KAŞ İbrahim ECE Abdominal Aorta ve Pelvik Arter Girişimleri Erbil ARIK Gürkan DANIŞAN Renal Arter Girişimleri Muhammet Kürşat ŞİMŞEK İsmail DİLEK Üst Ekstremite Arteriyel Girişimleri Hülya ÇETİN TUNÇEZ Alt Ekstremite Arteriyel Girişimleri Ahmet BAYRAK İntravasküler Yabancı Cisim Çıkarılması İsmail DİLEK Muhammet Kürşat ŞİMŞEK Periferik Venöz Anatomi Seçil GÜNDOĞDU Pediyatrik Venografi’ye Genel Bakış Sevgi DEMİRÖZ TAŞOLAR Periferik Vasküler Malformasyonlar Mehmet TURMAK Muhammed TEKİNHATUN Pediatrik Santral Venöz Girişimler Çağrı DAMAR Boyun ve Üst Ekstremite Venöz Girişimleri Merve HOROZ DÖNMEZ Lenfanjiografi ve Duktus Torasikus Embolizasyonu Samet GENEZ Portal ve Hepatik Venöz Girişimler, Konjenital Portosistemik Şant Tanı ve Tedavisi Ahmet BAYRAK Görüntüleme Eşliğinde Perkütan Biyopsiler Emre ALP Plevral Efüzyon ve Ampiyem Tedavisi Betül AKDAL DÖLEK Perkütan Apse ve Sıvı Drenajları Mustafa REŞORLU Fırathan SARIALTIN Perkütan Kist Hidatik Tedavisi Gülsüm Kübra BAHADIR Perkütan Gastrointestinal Girişimler Gülsüm Kübra BAHADIR Perkütan Biliyer Girişimler Mahmut DEMİRCİ Perkütan Üriner Sistem Girişimleri Mustafa YILDIRIM Hakan ARTAŞ Ahmet Kürşad POYRAZ Çocuklarda Perkütan Basit Renal Kist Tedavisi ve Perkütan Nefrolitotomi Gülşah BAYRAM ILIKAN Görüntüleme Eşliğinde Meme Girişimleri Seçil GÜNDOĞDU Pediatrik Kas İskelet Sistemi Girişimsel İşlemleri Kadir Han ALVER Görüntüleme Eşliğinde Tümör Ablasyonu Temel Prensipleri Uğur KESİMAL Retinoblastomda İntraarteriyel Kemoterapi Bedia KESİMAL Uğur KESİMAL
- Open Access
- 6 April 2023
- Published by Academician Publishing
Nörovasküler Radyoloji
Bu kitap temel ve ileri nörovasküler radyoloji konularını içerecek şekilde hazırlandı. Nörovasküler radyoloji konusunda bilgi edinmek isteyen tüm öğrenci, asistan ve uzmanlara faydalı olacağını ümit etmekteyiz.
- 6 April 2023
- Published by Academician Publishing
Open AccessNörovasküler Radyoloji
Bu kitap temel ve ileri nörovasküler radyoloji konularını içerecek şekilde hazırlandı. Nörovasküler radyoloji konusunda bilgi edinmek isteyen tüm öğrenci, asistan ve uzmanlara faydalı olacağını ümit etmekteyiz.
- Open Access
- 12 January 2023
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 29 (2) , 373-378
Did radiation exposure increase with chest CT use among different ages during the COVID-19 pandemic? A multi-center study with 42028 Chest CT scans
To determine whether radiation exposure increased among different ages with chest computed tomography (CT) use during the coronavirus disease-2019 (COVID-19) pandemic. Patients with chest CT scans in an 8-month period of the pandemic between March 15, 2020, and November 15, 2020, and the same period of the preceding year were included in the study. Indications of chest CT scans were obtained from the clinical notes and categorized as infectious diseases, neoplastic disorders, trauma, and other diseases. Chest CT scans for infectious diseases during the pandemic were compared with those with the same indications in 2019. The dose-length product values were obtained from the protocol screen individually. The total number of chest CT scans with an indication of infectious disease was 21746 in 2020 and 4318 in 2019. Total radiation exposure increased by 573% with the use of chest CT for infectious indications but decreased by 19% for neoplasia, 12% for trauma, and 43% for other reasons. The mean age of the patients scanned in 2019 was significantly higher than those scanned during the pandemic (64.6 vs. 50.3 years). A striking increase was seen in the 10-59 age group during the pandemic (P < 0.001). The highest increase was seen in the 20-29 age group, being 18.6 fold. One death was recorded per 58 chest CT scans during the pandemic. Chest CT use was substantially higher at the beginning of the pandemic. Chest CT was excessively used during the COVID-19 pandemic. Young and middle-aged people were exposed more than others. The impact of COVID-19-pandemic-related radiation exposure on public health should be followed carefully in future years.
- 12 January 2023
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 29 (2) , 373-378
Open AccessDid radiation exposure increase with chest CT use among different ages during the COVID-19 pandemic? A multi-center study with 42028 Chest CT scans
To determine whether radiation exposure increased among different ages with chest computed tomography (CT) use during the coronavirus disease-2019 (COVID-19) pandemic. Patients with chest CT scans in an 8-month period of the pandemic between March 15, 2020, and November 15, 2020, and the same period of the preceding year were included in the study. Indications of chest CT scans were obtained from the clinical notes and categorized as infectious diseases, neoplastic disorders, trauma, and other diseases. Chest CT scans for infectious diseases during the pandemic were compared with those with the same indications in 2019. The dose-length product values were obtained from the protocol screen individually. The total number of chest CT scans with an indication of infectious disease was 21746 in 2020 and 4318 in 2019. Total radiation exposure increased by 573% with the use of chest CT for infectious indications but decreased by 19% for neoplasia, 12% for trauma, and 43% for other reasons. The mean age of the patients scanned in 2019 was significantly higher than those scanned during the pandemic (64.6 vs. 50.3 years). A striking increase was seen in the 10-59 age group during the pandemic (P < 0.001). The highest increase was seen in the 20-29 age group, being 18.6 fold. One death was recorded per 58 chest CT scans during the pandemic. Chest CT use was substantially higher at the beginning of the pandemic. Chest CT was excessively used during the COVID-19 pandemic. Young and middle-aged people were exposed more than others. The impact of COVID-19-pandemic-related radiation exposure on public health should be followed carefully in future years.
- Open Access
- 26 December 2022
- Published by Izmir Democracy University in Izmir Democracy University Health Sciences Journal
- Vol. 5 (3) , 786-804
IS UPGRADE IN GLEASON SCORE AFTER RADICAL PROSTATECTOMY PREDICTABLE WITH PREOPERATIVE MULTIPARAMETRIC PROSTATE MRI?: COMPARISON OF ADC, K-TRANS, TUMOR SIZE AND PI-RADS SCORE
Aim: In this study, the relationship between MRI parameters and upgrade in Gleason score after radical prostatectomy was investigated. Materials and Methods: Between November 2017 and July 2020, 112 patients who underwent multiparametric MRI with suspected prostate cancer, TRUS systematic and cognitive fusion biopsy and subsequent radical prostatectomy were involved this study. The patients were evaluated in two groups as those with and without the Gleason score upgrade after surgery. These two groups was compared in terms of ADC, k-trans, tumor size and PI-RADS score. Radiological evaluation was consensus using PI-RADS version 2.1 by two radiologists who lacked clinical knowledge. ADC and k-trans were measured in the MR workstation. ISUP scoring system was used in pathological evaluation. Results: Upgrade in Gleason score was found in 51/112 of the cases. Only 2/51 cases were PI-RADS score 1. Upgrade rate of Gleason score were 15,6% for PI-RADS score <4; and 84,3% for score ≥4. The most frequent upgrade was from ISUP 1 to ISUP 2. There was no significant difference in PSA, PSAd tumor size, k-trans and ADC in comparing between two groups. Upgrade was significantly higher in cases with PI-RADS score ≥4 and the transitional zone involvement on MRI (p<0.05). Conclusion: mpMRI is an effective method of predicting upgrade in Gleason score after radical prostatectomy. PI-RADS score ≥4 or transitional zone involvement has an independent predictive value.
- 26 December 2022
- Published by Izmir Democracy University in Izmir Democracy University Health Sciences Journal
- Vol. 5 (3) , 786-804
Open AccessIS UPGRADE IN GLEASON SCORE AFTER RADICAL PROSTATECTOMY PREDICTABLE WITH PREOPERATIVE MULTIPARAMETRIC PROSTATE MRI?: COMPARISON OF ADC, K-TRANS, TUMOR SIZE AND PI-RADS SCORE
Aim: In this study, the relationship between MRI parameters and upgrade in Gleason score after radical prostatectomy was investigated. Materials and Methods: Between November 2017 and July 2020, 112 patients who underwent multiparametric MRI with suspected prostate cancer, TRUS systematic and cognitive fusion biopsy and subsequent radical prostatectomy were involved this study. The patients were evaluated in two groups as those with and without the Gleason score upgrade after surgery. These two groups was compared in terms of ADC, k-trans, tumor size and PI-RADS score. Radiological evaluation was consensus using PI-RADS version 2.1 by two radiologists who lacked clinical knowledge. ADC and k-trans were measured in the MR workstation. ISUP scoring system was used in pathological evaluation. Results: Upgrade in Gleason score was found in 51/112 of the cases. Only 2/51 cases were PI-RADS score 1. Upgrade rate of Gleason score were 15,6% for PI-RADS score <4; and 84,3% for score ≥4. The most frequent upgrade was from ISUP 1 to ISUP 2. There was no significant difference in PSA, PSAd tumor size, k-trans and ADC in comparing between two groups. Upgrade was significantly higher in cases with PI-RADS score ≥4 and the transitional zone involvement on MRI (p<0.05). Conclusion: mpMRI is an effective method of predicting upgrade in Gleason score after radical prostatectomy. PI-RADS score ≥4 or transitional zone involvement has an independent predictive value.
- 1 February 2021
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 22 (1) , 31-37
Predictors of Clinically Significant Prostate Cancer: A Comparative Study of PSA, PSA Density, and MRI Parameters
- 1 February 2021
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 22 (1) , 31-37
Predictors of Clinically Significant Prostate Cancer: A Comparative Study of PSA, PSA Density, and MRI Parameters
- 30 January 2021
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 11 (1) , 1-6
Interreader agreement in different PI-RADS systems in multiparametric prostate magnetic resonance imaging: A head-to-head comparison between PI-RADSv2 and v2.1
Aim The purpose of this study is to compare PI-RADSv2 with v2.1 in terms of interreader agreement and diagnostic performance in clinically significant prostate cancer (CSCa) detection. Materials and Methods Two hundred-two patients who had both multiparametric prostate magnetic resonance imaging (mpMRI) and 12 quadrant systematic biopsies were included in this retrospective study. Acquisition parameters were totally complied with proposal of PI-RADSv2 and 2.1 guidelines. mpMRIs were evaluated by two radiologists independently. Index lesion’s score was used to determine diagnostic performance of the systems. Gleason ≥ 3+4 tumors were considered CSCa. Kappa statistic was used to determine interreader agreement. Area under the curve (AUC) was calculated in detection of CSCa using receiver operating characteristic curve (ROC). Results The numbers of cases with PI-RADSv2 and v2.1 scores from 1 to 5 were 46, 21, 13, 41, 81 and 46, 26, 9, 43, 78, by reader 1 and 51, 10, 18, 43, 80 and 51, 15, 19, 37, 80 by reader 2, respectively. There was “substantial” agreement between two readers for both scoring systems. Kappa values were 0.600 in PI-RADSv2 and 0.624 in PI-RADSv2.1. Ninety-eight (48.5%) patients had CSCa. AUC values of PI-RADSv2 and v2.1 scoring systems were 0.861 and 0.851 for reader 1, 0.873 and 0.883 for reader 2, respectively. Conclusion Interreader agreement was “substantial” in mpMRI and slightly improved with PI-RADSv2.1. Diagnostic performance of the two systems were almost equal.
- 30 January 2021
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 11 (1) , 1-6
Interreader agreement in different PI-RADS systems in multiparametric prostate magnetic resonance imaging: A head-to-head comparison between PI-RADSv2 and v2.1
Aim The purpose of this study is to compare PI-RADSv2 with v2.1 in terms of interreader agreement and diagnostic performance in clinically significant prostate cancer (CSCa) detection. Materials and Methods Two hundred-two patients who had both multiparametric prostate magnetic resonance imaging (mpMRI) and 12 quadrant systematic biopsies were included in this retrospective study. Acquisition parameters were totally complied with proposal of PI-RADSv2 and 2.1 guidelines. mpMRIs were evaluated by two radiologists independently. Index lesion’s score was used to determine diagnostic performance of the systems. Gleason ≥ 3+4 tumors were considered CSCa. Kappa statistic was used to determine interreader agreement. Area under the curve (AUC) was calculated in detection of CSCa using receiver operating characteristic curve (ROC). Results The numbers of cases with PI-RADSv2 and v2.1 scores from 1 to 5 were 46, 21, 13, 41, 81 and 46, 26, 9, 43, 78, by reader 1 and 51, 10, 18, 43, 80 and 51, 15, 19, 37, 80 by reader 2, respectively. There was “substantial” agreement between two readers for both scoring systems. Kappa values were 0.600 in PI-RADSv2 and 0.624 in PI-RADSv2.1. Ninety-eight (48.5%) patients had CSCa. AUC values of PI-RADSv2 and v2.1 scoring systems were 0.861 and 0.851 for reader 1, 0.873 and 0.883 for reader 2, respectively. Conclusion Interreader agreement was “substantial” in mpMRI and slightly improved with PI-RADSv2.1. Diagnostic performance of the two systems were almost equal.